CAVERJECT IMPULSE Drug Patent Profile
✉ Email this page to a colleague
When do Caverject Impulse patents expire, and what generic alternatives are available?
Caverject Impulse is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in CAVERJECT IMPULSE is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Caverject Impulse
A generic version of CAVERJECT IMPULSE was approved as alprostadil by HIKMA on January 20th, 1998.
Summary for CAVERJECT IMPULSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 4,457 |
Drug Prices: | Drug price information for CAVERJECT IMPULSE |
What excipients (inactive ingredients) are in CAVERJECT IMPULSE? | CAVERJECT IMPULSE excipients list |
DailyMed Link: | CAVERJECT IMPULSE at DailyMed |
Pharmacology for CAVERJECT IMPULSE
Drug Class | Prostaglandin Analog Prostaglandin E1 Agonist |
Mechanism of Action | Prostaglandin Receptor Agonists |
Physiological Effect | Genitourinary Arterial Vasodilation Venous Vasodilation |
Anatomical Therapeutic Chemical (ATC) Classes for CAVERJECT IMPULSE
US Patents and Regulatory Information for CAVERJECT IMPULSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | CAVERJECT IMPULSE | alprostadil | INJECTABLE;INJECTION | 021212-001 | Jun 11, 2002 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | CAVERJECT IMPULSE | alprostadil | INJECTABLE;INJECTION | 021212-002 | Jun 11, 2002 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CAVERJECT IMPULSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | CAVERJECT IMPULSE | alprostadil | INJECTABLE;INJECTION | 021212-001 | Jun 11, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | CAVERJECT IMPULSE | alprostadil | INJECTABLE;INJECTION | 021212-002 | Jun 11, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | CAVERJECT IMPULSE | alprostadil | INJECTABLE;INJECTION | 021212-001 | Jun 11, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CAVERJECT IMPULSE
See the table below for patents covering CAVERJECT IMPULSE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 69433044 | ⤷ Try a Trial | |
European Patent Office | 0947209 | Fabrication de cartouche d'injection (Injection cartridge manufacture) | ⤷ Try a Trial |
New Zealand | 225181 | METHOD AND DEVICE FOR THE PREPARATION OF AN INJECTION SOLUTION | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |